1-11 of 11
Authors: Marius Stan
Journal Article
12231 PAPP-A As A Potential Target In Thyroid Eye Disease Open Access
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.2031, https://doi.org/10.1210/jendso/bvae163.2031
Published: 05 October 2024
Journal Article
OR27-04 Efficacy And Safety Results From The Randomized, Placebo-controlled Multicenter Trial With Teprotumumab In Chronic-Low Clinical Activity Score Thyroid Eye Disease Patients Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.2055, https://doi.org/10.1210/jendso/bvad114.2055
Published: 05 October 2023
Journal Article
SAT470 Outcomes Of Radiofrequency Ablation For Autonomously Functioning Thyroid Adenoma- Mayo Clinic Experience Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.1944, https://doi.org/10.1210/jendso/bvad114.1944
Published: 05 October 2023
Journal Article
RF35 | PSAT269 Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase 2b Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease Open Access
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A862, https://doi.org/10.1210/jendso/bvac150.1782
Published: 01 November 2022
Journal Article
PSAT245 Feasibility of introducing a conversation aid for patients with thyroid nodules in clinical practice: Understanding the clinician experience Open Access
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A805, https://doi.org/10.1210/jendso/bvac150.1666
Published: 01 November 2022
Journal Article
Early Biochemical Response to Antithyroid Drugs in Graves’ Disease: The Role of Initial Dosing Open Access
Journal of the Endocrine Society, Volume 5, Issue Supplement_1, April-May 2021, Page A829, https://doi.org/10.1210/jendso/bvab048.1690
Published: 03 May 2021
Journal Article
SAT-423 Anti-thyroid Drug Response in Graves’ Disease: Predictors of Biochemically Persistent Disease Open Access
Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020, SAT-423, https://doi.org/10.1210/jendso/bvaa046.291
Published: 08 May 2020
Journal Article
MON-623 Higher FT4 Results in Levothyroxine-Treated Patients with Normal TSH Compared to Patients without Thyroid Disease Open Access
Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-623, https://doi.org/10.1210/js.2019-MON-623
Published: 30 April 2019
Journal Article
OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism Open Access
Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, OR19-6, https://doi.org/10.1210/js.2019-OR19-6
Published: 30 April 2019
Journal Article
SAT-LB100 Suspicious Thyroid Nodules: Management Since the Introduction of 2015 ATA Guidelines Open Access
Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, SAT-LB100, https://doi.org/10.1210/js.2019-SAT-LB100
Published: 30 April 2019
Journal Article
OR19-3 Utility of the Levothyroxine Absorption Test: The Mayo Clinic Experience Open Access
Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, OR19-3, https://doi.org/10.1210/js.2019-OR19-3
Published: 30 April 2019
